JAG Shaw Baker’s strategic commercial and corporate legal practice is focused on the life sciences, clean tech and digital technology markets.

We specialise in UK, US and European corporate finance, investment, M&A, intellectual property, commercial contracts, due diligence and general counsel matters for every stage of a company’s life.

Our UK and US trained lawyers provide practical business guidance and collaborative advice to entrepreneurs, companies and investors in their business transactions and relationships with commercial and corporate partners. JAG Shaw Baker is also a gateway to Europe for US entrepreneurs and global VC investors.

Practices

Ad Clearance / Branding & Trade Mark Protection  /  Capital Markets  /  Commercial Contracts  /  Copyrights  /  Corporate Governance & Shareholder Issues  /  Debt & Equity  /  Due Diligence  /  Formations & Company Administration  /  Financial Transactions  / General Counsel  /  Intellectual Property  /  Investment Funds  /  Intellectual Property Disputes / Life Sciences Licensing  /  M&A and Exits  /  Privacy & Data Protection  /  Private Equity  / Shareholder Agreements  /  Structuring & Restructuring  /  Technology Transactions  /  Terms & Conditions  /   Venture Capital

Markets

Digital Media & Entertainment /  Clean Technology  /  Computer Hardware & Software  / e-Commerce   /  Education Technology  /  Fashion Technology  / Financial Technology  /  Internet & Social Investment Funds / Life Sciences, healthcare & biotech  / Media  /  Media & New Media  /  Medical Devices / Venture Capital

LIFE SCIENCES

Helping innovative drugs and therapies go to market.

We have one of the most renowned life sciences practices in the UK. We help companies commercialise technology and scientific discoveries. Our life sciences practice helps companies bring more innovative drugs, therapies and devices to the market which helps people live longer and healthier lives.

We have solid experience in helping companies develop, test and commercialise pharmaceutical products through their entire life cycle. We help companies invest and commercialise in technology and scientific discoveries.

Our clients include pharmaceuticals, biotechs, medical devices and healthcare companies.

Specific areas of focus include:

  • Confidentiality agreements and term sheets
  • Material transfer agreements
  • Clinical trial agreements with CROs, institutions and  investigators
  • Master services agreements
  • Co-promotion and co-marketing agreements
  • Licences and option agreements
  • Research collaboration and joint venture agreements
  • Manufacturing, supply and distribution agreements
  • Advice on compliance issues, including in relation to the ABPI   code, clinical trial regulation, study advertisements and clinical trial compensation guidelines

Fast Facts

Outsourced General Counsel to a number of life sciences companies including leading oncology company on all legal matters including pre-clinical trials and phase 3 clinical trials.

Advised on phase 3 clinical trial negotiation and contract management for four major biotech companies.

Negotiated clinical trial agreements for clients in more than 40 countries.

Advised UK-based company on a co-development agreement with US multinational for the development and approval of a leukaemia drug.

Advisers to early stage biotech and life sciences companies on regulatory compliance and IP portfolio acquisitions.

Advised founders on spin-out from Cambridge University and advised several biotech companies on significant fundraising rounds to support their drug development programmes.

Adviser to several life sciences venture capital fund investors on equity investments.

CORPORATE

We provide unparalleled insight into the finer details of acquisition and international expansion.

Our corporate team has a unique set of legal expertise to meet the business nuances of investors, VCs and high-growth companies.

And, no matter what name the UK startup market goes by – Tech City, Silicon Roundabout, Silicon Allee, Cambridge Cluster, or the Manchester Tech scene – JAG Shaw Baker’s practice is always centered on supporting the UK and European technology market with strategic legal advice and business guidance through every stage of a company’s lifecycle.

We work with key contributors and stakeholders in the European tech community including start-ups and incubators, multinational enterprises and government organizations.

We also partner with leading European VC firms and accelerators to advise investors on the best path to take to protect those investments and help build the business through to a successful exit.

Fast Facts

JAG Shaw Baker has worked with more than 200 digital technology companies on seed, Series A-E, M&A and IPO transactions.

Our venture capital team advised on more than 180 transactions in 2015 and more than 46 investor-side financings in 2015.

We represented more than 130 company-side financing matters in 2015 and more than 88 venture and growth investors.

We are advisers to the BVCA drafting committee for Model Series A documents as well as number of VCs preparing model form equity documents.

We drafted UKISS and ASA documents to create a standardized framework for UK startups for leading accelerators including Seedsummit, Seedcamp and 500 Startups.

Represented a major syndicate of VCs on pre-IPO reorganization of the sale preference prior to the IPO.

Representing five VC/PE-backed companies on exit strategies with independently assessed values of in excess of $4 billion.

Intellectual Property

Helping clients protect their IP, brand & investment for expansion and growth.

We have one of the strongest intellectual property (IP) and brand protection practices in the UK.  Our specialised team advises on the commercialisation, exploitation and enforcement of IP rights, covering contentious and non-contentious issues relating to patents, trade marks, copyright and other IP rights.

From advising a children’s e-publishing business on various prize competitions including sending the winner’s book to be read on the International Space Station to anti-counterfeiting support for a global financial services provider in Europe, US, China and Australia, our IP practice helps high-growth companies protect their investment so they can expand without worry and focus on their business.

We are specialists in these areas:

  • Negotiating and drafting licensing and commercial agreements
  • National and international collaborations
  • Research and development arrangements
  • Data protection and privacy strategy
  • IP protection and strategies
  • Internet law
  • Brand and trade mark protection

Fast Facts

Negotiated various licensing and IP agreements with governmental and academic research institutions worldwide, including Cuba.

Advisors to a 3D mapping technology business on interior 3D mapping for public arenas and event spaces.

Ongoing advisers to life sciences and corporate clients on anti-cybersquatting, anti-piracy programs and EU privacy regulations.

Won a successful appeal to the Independent Reviewer of ASA adjudications against high profile disruptive advertising.

Worldwide brand protection for a number of clients including a global digital music technology business.

Advised a UK-based telecommunications provider on contractual claims against a global telco business and their rights in relation to telecommunications regulator.

Advisers on licence arrangements with parties in the US, Europe and Japan for multinational print technology business.

Advising life sciences businesses on clinical trial arrangements and IP licensing in multiple jurisdictions.